$40 billion is like, wow 🤯 they're basically betting on Kenvue's portfolio of brands being worth it. I mean, Listerine and Neutrogena are huge names, so maybe Kimberly-Clark just wants to capitalize on that. But the whole autism thing with Tylenol is still super weird 😕. Like, did they really...